Venza M - Search Results

1

Innovative therapeutic strategies in the treatment of brain metastases.

Caffo M, Barresi V, Caruso G, Cutugno M, La Fata G, Venza M, Alafaci C, Tomasello F. Caffo M, et al. Among authors: venza m. Int J Mol Sci. 2013 Jan 22;14(1):2135-74. doi: 10.3390/ijms14012135. Int J Mol Sci. 2013. PMID: 23340652 Free PMC article.

2

Interleukin-8 overexpression in astrocytomas is induced by prostaglandin E2 and is associated with the transcription factors CCAAT/enhancer-binding protein-β and CCAAT/enhancer-binding homologous protein.

Venza M, Visalli M, Alafaci C, Caffo M, Caruso G, Salpietro FM, Tomasello F, Teti D. Venza M, et al. Neurosurgery. 2011 Sep;69(3):713-21; discussion 721. doi: 10.1227/NEU.0b013e31821954c6. Neurosurgery. 2011. PMID: 21471847

3

PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation.

Venza I, Visalli M, Fortunato C, Ruggeri M, Ratone S, Caffo M, Caruso G, Alafaci C, Tomasello F, Teti D, Venza M. Venza I, et al. Among authors: venza m. Epigenetics. 2012 Nov;7(11):1315-30. doi: 10.4161/epi.22446. Epub 2012 Oct 10. Epigenetics. 2012. PMID: 23051921 Free PMC article.

4

Epigenetic effects of cadmium in cancer: focus on melanoma.

Venza M, Visalli M, Biondo C, Oteri R, Agliano F, Morabito S, Caruso G, Caffo M, Teti D, Venza I. Venza M, et al. Among authors: venza i. Curr Genomics. 2014 Dec;15(6):420-35. doi: 10.2174/138920291506150106145932. Curr Genomics. 2014. PMID: 25646071 Free PMC article.

5

Heavy metals and epigenetic alterations in brain tumors.

Caffo M, Caruso G, Fata GL, Barresi V, Visalli M, Venza M, Venza I. Caffo M, et al. Among authors: venza i, venza m. Curr Genomics. 2014 Dec;15(6):457-63. doi: 10.2174/138920291506150106151847. Curr Genomics. 2014. PMID: 25646073 Free PMC article.

6

Potential Role of Carbon Nanomaterials in the Treatment of Malignant Brain Gliomas.

Caffo M, Curcio A, Rajiv K, Caruso G, Venza M, Germanò A. Caffo M, et al. Among authors: venza m. Cancers (Basel). 2023 Apr 30;15(9):2575. doi: 10.3390/cancers15092575. Cancers (Basel). 2023. PMID: 37174040 Free PMC article. Review.

7

DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.

Venza M, Visalli M, Catalano T, Biondo C, Beninati C, Teti D, Venza I. Venza M, et al. Among authors: venza i. Oncol Rep. 2016 Apr;35(4):2451-60. doi: 10.3892/or.2016.4618. Epub 2016 Feb 11. Oncol Rep. 2016. PMID: 26883095

8

FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma.

Venza I, Visalli M, Tripodo B, De Grazia G, Loddo S, Teti D, Venza M. Venza I, et al. Among authors: venza m. Br J Dermatol. 2010 May;162(5):1093-7. doi: 10.1111/j.1365-2133.2009.09560.x. Epub 2009 Oct 21. Br J Dermatol. 2010. PMID: 19845668

9

The overriding of TRAIL resistance by the histone deacetylase inhibitor MS-275 involves c-myc up-regulation in cutaneous, uveal, and mucosal melanoma.

Venza M, Visalli M, Oteri R, Agliano F, Morabito S, Teti D, Venza I. Venza M, et al. Among authors: venza i. Int Immunopharmacol. 2015 Sep;28(1):313-21. doi: 10.1016/j.intimp.2015.06.024. Epub 2015 Jun 27. Int Immunopharmacol. 2015. PMID: 26122536

10

Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis.

Venza M, Visalli M, Beninati C, Biondo C, Teti D, Venza I. Venza M, et al. Among authors: venza i. Anticancer Agents Med Chem. 2016;16(5):528-38. doi: 10.2174/1871520615666150803124139. Anticancer Agents Med Chem. 2016. PMID: 26234362 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters